If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Virginia can and should tackle prescription drug affordability, but not with policies that create more problems than they ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...

If you ask any Missouri family what's stretching their wallets the most, you'll likely hear the same thing: higher prices on everything.

Gov. Kathy Hochul announced Monday a new program, “DFS Connect,” that will make it easier for New Yorkers to file complaints ...

Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers (including employers, insurers, and pharmacy benefit managers), regulators, ...

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

Warning that the state’s health care system is “falling apart,” the Senate’s point person on the topic said that she wants to ...

Claire Lindell had to wait months for treatment when doctors in April 2020 were forced to suddenly cancel the little girl’ s spine surgery. “That was a tough period,” recalled her father, A.J. Lindell ...